By Karlee Weinmann ( April 29, 2014, 6:09 PM EDT) -- Pfizer Inc. this week outlined a prospective $100 billion merger with British rival AstraZeneca PLC that could suck billions of tax dollars out of the U.S., shining a brighter spotlight on the fast-rising number of stateside companies, some of them giants, eyeing cross-border moves in part to lighten their tax loads....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.